SCYNEXIS
Latest round
- Series D
Last raised
- Dec 2011
Total raised
- $48M
Investors
- 7
About SCYNEXIS
SCYNEXIS, Inc. is a biopharmaceutical company focused on developing innovative antifungal therapies for serious infections.SCYNEXIS, Inc. develops antifungal treatments specifically targeting serious fungal infections. Headquartered in Durham, North Carolina, the company has pivoted its focus over the years, emphasizing the commercialization of its lead drug, Ibrexafungerp. SCYNEXIS, Inc. was founded by a team of experienced professionals in the pharmaceutical industry.00 mn.SCYNEXIS specializes in the development and commercialization of antifungal therapies, focusing on difficult-to-treat fungal infections. Their lead product, Ibrexafungerp, represents a novel class known as 'fungerps' and is designed to combat antifungal-resistant pathogens. The company's products target healthcare providers, particularly hospitals and specialty clinics, where the incidence of these infections is rising.12 mn.SCYNEXIS, Inc. The company is targeting additional markets in Europe and Asia for its treatments, with strategic timelines for expansion yet to be disclosed.
Who invested in SCYNEXIS
7 investors across 3 rounds
See all investors in SCYNEXIS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SCYNEXIS
Who invested in SCYNEXIS?
SCYNEXIS has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SCYNEXIS raised?
SCYNEXIS has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did SCYNEXIS last raise money?
SCYNEXIS's most recent round on record is a Series D, in Dec 2011.
What does SCYNEXIS do?
SCYNEXIS is a pharmaceuticals company.
Where is SCYNEXIS headquartered?
SCYNEXIS is headquartered in US.
Which VCs invest in companies like SCYNEXIS?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at SCYNEXIS's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like SCYNEXIS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.